from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2332/mez

LFCtreatmentdescriptionclass of inhibitor

0.625

Amikacinug/mL Amikacintranslation

1.514

Cap5-10ug/mL Capreomycintranslation

1.499

Rox10-50 ug/mL Roxithromycintranslation

-0.501

SM2-5 ug/mL Streptomycintranslation

2.107

Tet5-10 ug/mL Tetracyclinetranslation

-0.301

Rif0.2-5ug/mL Rifampicintranscription

-0.054

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.175

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.378

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.052

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.688

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.586

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.332

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.574

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.583

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.234

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.903

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.845

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.168

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.773

KCN5-20 ug/mL Potassium cyaniderespiration

-1.047

NaN30.2-2 mM Sodium aziderespiration

-0.125

Nigericin50 uM Nigericinrespiration

0.778

TRC10-150 ug/mL Triclosanrespiration

0.114

TRZ10-25 ug/mL Thioridazinerespiration

0.540

Valinomycin0.5-10 uM Valinomycinrespiration

0.105

ZnSO42 mM ZnSO4respiration

0.538

menadione6-10 ug/mL Menadionerespiration

-0.452

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.594

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.391

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.356

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.435

NRP_1Non-replicating persistence stage 1dosRassociated

-0.431

Amp0.2mg/mL AmpicillincellWall

-0.484

Cephalexin20-100 ug/mL CephalexincellWall

-0.453

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.818

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.689

EMB10-20 ug/mL EthambutolcellWall

-0.882

Eta12-40 ug/mL EthionamidecellWall

-1.143

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.528

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.494

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.763

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.313

BZA0.12 mg/mL BenzamidearomaticAmides

0.483

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.159

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.056

H2O24 mM hydrogen peroxideDNAdamaging

-0.516

Levo10 ug/mL LevofloxacinDNAdamaging

-0.210

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.283

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.378

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.375

UVUV-irradiationDNAdamaging

1.563

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.478

Antimycin12.5-50 ug/mL Antimycin A?

-0.246

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.598

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.538

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.939

PA8240.2-2 ug/mL PA-824?

-1.016

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.629

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.481

Verapamil50 uM Verapamil?

0.027

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.332

methoxatin10-20 ug/mL Methoxatin?